Stepan (SCL) just refreshed its lending toolkit with a new US$500 million credit agreement, expanding available borrowing capacity and extending maturities in a move tied directly to funding operations and potential acquisitions.
Recent trading tells a mixed story for Stepan. The 90 day share price return of 12.84% and year to date gain of 32.29% point to building momentum, even though the 1 year total shareholder return of 34.83% contrasts with a 5 year total shareholder return that is down 42.25%.
Compare Stepan's renewed funding flexibility with a hand-picked list of solid balance sheet and fundamentals (25 results) that may also be positioning for acquisitions and long term investment plans.
Stepan’s share price has rebounded while long-term holders are still underwater, and the new US$500 million credit line adds fresh optionality. Is most of the rerating already captured, or is there meaningful upside left?
Most Popular Narrative: 26.6% Undervalued
Compared with Stepan’s last close at $62.39, the prevailing narrative fair value of $85 points to a sizeable valuation gap that hinges on cost savings and mix improvement actually flowing through the income statement.
Ongoing Project Catalyst actions, including site closures such as Fieldsboro and asset decommissioning in Millsdale and Stalybridge, together with targeted salaried headcount and procurement efficiencies, are expected to support the approximately US$100 million pretax savings plan over two years and could reset Stepan’s cost base in a way that benefits earnings quality and margins.
See why 6 investors see Stepan as 27% undervalued.
Result: Fair Value of $85 (UNDERVALUED)
Still, Stepan’s story can unravel if high interest rates keep pressuring rigid polyol demand, or if another round of raw material spikes squeezes surfactant margins again.
Find out about the key risks to this Stepan narrative.
Next Steps
Sentiment around Stepan is split, with both concern and optimism in the mix. Move quickly, review the data, and pressure test the 2 key rewards and 2 important warning signs.
Looking for more Stepan-sized investment ideas?
You do not need to stop with Stepan. Put the same disciplined lens over a wider watchlist so you are not relying on a single opportunity.
- Target resilient balance sheets by scanning a list of solid balance sheet and fundamentals (25 results) that can handle shocks without constant refinancing worry.
- Hunt for quality at a discount through a focused 27 high quality undervalued stocks that highlights companies with stronger fundamentals than their current pricing implies.
- Build a cash focused watchlist using a 8 dividend fortresses that filters for higher yielding businesses with the capacity to keep paying investors.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com